Management of rheumatoid arthritis: the 2012 perspective

Studies of the efficacy and safety of methotrexate at dosages over 8 mg/week using the IORRA cohort database

(2014) Yohei Seto et al.   Modern Rheumatology

2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

(2012) Jasvinder A. Singh et al.   ARTHRITIS CARE & RESEARCH

A large-scale association study identified multiple HLA-DRB1 alleles associated with ACPA-negative rheumatoid arthritis in Japanese subjects

(2011) C. Terao et al.   ANNALS OF THE RHEUMATIC DISEASES

American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

(2011) D. T. Felson et al.   ANNALS OF THE RHEUMATIC DISEASES

The relationship between oral contraceptive use and functional outcome in women with recent-onset inflammatory polyarthritis: Results from the Norfolk Arthritis Register

(2011) E. M. Camacho et al.   ARTHRITIS AND RHEUMATISM

Comparative Pharmacokinetics and Tolerability of Branded Etanercept (25 mg) and Its Biosimilar (25 mg): A Randomized, Open-Label, Single-Dose, Two-Sequence, Crossover Study in Healthy Korean Male Volunteers

(2011) Namyi Gu et al.   CLINICAL THERAPEUTICS

New therapies in the management of rheumatoid arthritis

(2011) Maya H Buch et al.   CURRENT OPINION IN RHEUMATOLOGY

Predictive, personalized, preventive, participatory (P4) cancer medicine

(2011) Leroy Hood et al.   Nature Reviews Clinical Oncology

Spleen Tyrosine Kinase (Syk) Inhibitor for Rheumatoid Arthritis

(2011)   NEW ENGLAND JOURNAL OF MEDICINE

Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis

(2010) J. D. Greenberg et al.   ANNALS OF THE RHEUMATIC DISEASES

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

(2010) J. S. Smolen et al.   ANNALS OF THE RHEUMATIC DISEASES

2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

(2010) D. Aletaha et al.   ANNALS OF THE RHEUMATIC DISEASES

Association of EMCN with Susceptibility to Rheumatoid Arthritis in a Japanese Population

(2010) K. NISHIMOTO et al.   JOURNAL OF RHEUMATOLOGY

A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility

(2010) Yuta Kochi et al.   NATURE GENETICS

Understanding the Relationship between the EQ-5D, SF-6D, HAQ and Disease Activity in Inflammatory Arthritis

(2010) Roisin Adams et al.   PHARMACOECONOMICS

Mortality and cause of death in Japanese patients with rheumatoid arthritis based on a large observational cohort, IORRA

(2010) A Nakajima et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Change of synovial vascularity in a single finger joint assessed by power doppler sonography correlated with radiographic change in rheumatoid arthritis: Comparative study of a novel quantitative score with a semiquantitative score

(2010) Jun Fukae et al.   ARTHRITIS CARE & RESEARCH

Association study of TRAF1-C5 polymorphisms with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese

(2009) K Nishimoto et al.   ANNALS OF THE RHEUMATIC DISEASES

A Personal Journey of Discovery: Developing Technology and Changing Biology

(2008) Lee Hood   Annual Review of Analytical Chemistry

Efficient management of rheumatoid arthritis significantly reduces long-term functional disability

(2007) E Tanaka et al.   ANNALS OF THE RHEUMATIC DISEASES